Background
Ventilator‐associated pneumonia (VAP) is one of the most common causes of nosocomial pneumonia in ventilated neonates. Nevertheless, its diagnosis is challenging due to the nonspecific clinical parameters and the lack of sensitive biomarkers. The main objective of this study was to compare soluble triggering receptors expressed on myeloid cells‐1 (sTREM‐1) and 25‐hydroxy vitamin D as early predictors of neonatal VAP.
Methods
This prospective cohort study included 85 ventilated neonates divided into the VAP group (n = 33) and the non‐VAP group (n = 52). sTREM‐1 levels in the endotracheal aspirate (ETA) and serum 25‐hydroxy vitamin D levels were measured on the third and seventh days following mechanical ventilation. The Ethical and Research Committee approved the study at Tanta University Hospitals, Egypt (with the Approval code: 32751/12/18).
Results
The sTREM‐1 cutoff value of >0.46 and >0.44 ng/ml at 3 and 7 days had a sensitivity of 93.94% and 96.97%, a specificity of 92.31% and 100%, and an area under the receiver operating characteristic curve (AUC) of 0.963 and 0.993, respectively, to predict the development of neonatal VAP. A serum 25‐hydroxy vitamin D cutoff value of ≤17.5 ng/ml at 3 and 7 days had a sensitivity of 90.91% and 81.82%, a specificity of 75% and 78.85%, and area under the curve of 0.877 and 0.939, respectively.
Conclusion
Both sTREM‐1 in ETA and serum 25‐hydroxy vitamin D could be used as early predictors of neonatal VAP, but sTREM‐1 appears more useful.